Anti‐IL‐12/IL‐23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod‐induced psoriasis‐like dermatitis
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2018.03.018
Abstract: ABSTRACT Psoriasis is a chronic inflammatory skin disease characterized by erythema, skin hyperplasia, scales, and keratinocyte hyperproliferation. While the cause of psoriasis is not clearly understood, a dysregulated immune system, especially activation of IL‐23/IL‐17 axis,… read more here.
Keywords: dysfunction mice; barrier dysfunction; psoriasis; dermatitis ... See more keywords